ResMed Inc. (ASX: RMD) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
ResMed Inc. Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
ResMed Inc. (ASX: RMD)
Latest News
⏸️ Investor Education
Here's how you can boost your wealth
Healthcare Shares
Citi has just upgraded CSL Limited (ASX:CSL) to "buy"
Share Market News
Are these the best blue chip shares on the ASX?
Growth Shares
Is CSL Limited's (ASX:CSL) share price heading back above $200?
Growth Shares
3 top healthcare shares that could be market-beaters in FY 2019
Growth Shares
Why I think WiseTech Global Ltd (ASX:WTC) will lag in any upcoming share market rally
Healthcare Shares
Is ResMed Inc. (CHESS) (ASX:RMD) under threat from this high growth innovator?
⏸️ ASX Shares
Are these healthcare shares in the buy zone?
Share Fallers
ResApp Health Ltd (ASX:RAP) shares slide lower despite strong obstructive sleep apnoea study results
Share Market News
Why ASX investors shouldn't fear the spike in the 10-year Treasury yield
Growth Shares
3 top healthcare shares I would buy this week
Share Market News
Where I would invest $10,000 in the share market
Frequently Asked Questions
-
Yes. As well as being listed on the ASX since November 1999, ResMed trades on the New York Stock Exchange under the ticker code NYSE: RMD.
-
Yes, historically ResMed pays unfranked quarterly dividends each year. It does not offer a dividend reinvestment plan.
RMD ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About ResMed Inc.
ResMed Inc (ASX: RMD) is a global leader in sleep technology. It develops, manufactures, and distributes medical devices – such as flow generators, CPAP masks, and accessories – and cloud-based software applications that diagnose, treat, and manage a range of respiratory disorders including sleep apnea, chronic obstructive pulmonary disease (COPD), and neuromuscular disease.
It also provides software platforms to support professionals and caregivers to help patients in an out-of-hospital setting. The company operates in more than 140 countries, with manufacturing facilities in Australia, Singapore, France, and the United States. ResMed was established in Australia in 1989 but is now based in San Diego in the United States.
